Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride treats enlarged prostate and hair loss, but may cause side effects in some patients.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Neuroactive steroids may affect the risk and treatment of alcohol use disorders.

Finasteride improves hair growth in men with androgenetic alopecia.

Licorice extract helps hair growth and may treat hair loss.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Oral lichen planus is not linked to sex hormone levels.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Finasteride might affect memory by impacting cholinergic system.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

DHT, a testosterone byproduct, causes male pattern baldness.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.